Vanda Pharmaceuticals (VNDA) Tops Q3 EPS by 4c
Tweet
Share
E-mail
Get Alerts VNDA Hot Sheet
Price: $5.13 +1.79%
Revenue Growth %: +24.1%
Financial Fact:
Intangible asset amortization: 2.94M
Today's EPS Names:
ANAB, ANIX, MNY, More
Revenue Growth %: +24.1%
Financial Fact:
Intangible asset amortization: 2.94M
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q3 EPS of $0.00, $0.04 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $38.82 million versus the consensus estimate of $44.5 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
- GE Vernova (GEV) PT Raised to $1,185 at Jefferies
- Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
